225 related articles for article (PubMed ID: 11743396)
1. From genotype to phenotype: the differential expression of FGF, FGFR, and TGFbeta genes characterizes human cranioskeletal development and reflects clinical presentation in FGFR syndromes.
Britto JA; Evans RD; Hayward RD; Jones BM
Plast Reconstr Surg; 2001 Dec; 108(7):2026-39; discussion 2040-6. PubMed ID: 11743396
[TBL] [Abstract][Full Text] [Related]
2. Negative autoregulation of fibroblast growth factor receptor 2 expression characterizing cranial development in cases of Apert (P253R mutation) and Pfeiffer (C278F mutation) syndromes and suggesting a basis for differences in their cranial phenotypes.
Britto JA; Moore RL; Evans RD; Hayward RD; Jones BM
J Neurosurg; 2001 Oct; 95(4):660-73. PubMed ID: 11596961
[TBL] [Abstract][Full Text] [Related]
3. Toward pathogenesis of Apert cleft palate: FGF, FGFR, and TGF beta genes are differentially expressed in sequential stages of human palatal shelf fusion.
Britto JA; Evans RD; Hayward RD; Jones BM
Cleft Palate Craniofac J; 2002 May; 39(3):332-40. PubMed ID: 12019011
[TBL] [Abstract][Full Text] [Related]
4. Fgfr mRNA isoforms in craniofacial bone development.
Rice DP; Rice R; Thesleff I
Bone; 2003 Jul; 33(1):14-27. PubMed ID: 12919696
[TBL] [Abstract][Full Text] [Related]
5. Spatio-temporal expression of FGFR 1, 2 and 3 genes during human embryo-fetal ossification.
Delezoide AL; Benoist-Lasselin C; Legeai-Mallet L; Le Merrer M; Munnich A; Vekemans M; Bonaventure J
Mech Dev; 1998 Sep; 77(1):19-30. PubMed ID: 9784595
[TBL] [Abstract][Full Text] [Related]
6. Integration of FGF and TWIST in calvarial bone and suture development.
Rice DP; Aberg T; Chan Y; Tang Z; Kettunen PJ; Pakarinen L; Maxson RE; Thesleff I
Development; 2000 May; 127(9):1845-55. PubMed ID: 10751173
[TBL] [Abstract][Full Text] [Related]
7. Fgfr1 and Fgfr2 have distinct differentiation- and proliferation-related roles in the developing mouse skull vault.
Iseki S; Wilkie AO; Morriss-Kay GM
Development; 1999 Dec; 126(24):5611-20. PubMed ID: 10572038
[TBL] [Abstract][Full Text] [Related]
8. FGF signaling in craniofacial biological control and pathological craniofacial development.
Hatch NE
Crit Rev Eukaryot Gene Expr; 2010; 20(4):295-311. PubMed ID: 21395503
[TBL] [Abstract][Full Text] [Related]
9. Description of a new mutation and characterization of FGFR1, FGFR2, and FGFR3 mutations among Brazilian patients with syndromic craniosynostoses.
Passos-Bueno MR; Sertié AL; Richieri-Costa A; Alonso LG; Zatz M; Alonso N; Brunoni D; Ribeiro SF
Am J Med Genet; 1998 Jul; 78(3):237-41. PubMed ID: 9677057
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of fibroblast growth factor receptors in human digital development suggests common pathogenesis in complex acrosyndactyly and craniosynostosis.
Britto JA; Chan JC; Evans RD; Hayward RD; Jones BM
Plast Reconstr Surg; 2001 May; 107(6):1331-8; discussion 1339-45. PubMed ID: 11335797
[TBL] [Abstract][Full Text] [Related]
11. Localisation and differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal and atherosclerotic human arteries.
Hughes SE
Cardiovasc Res; 1996 Sep; 32(3):557-69. PubMed ID: 8881516
[TBL] [Abstract][Full Text] [Related]
12. [Genetics of craniofacial development].
van Adrichem LN; Hoogeboom AJ; Wolvius EB
Ned Tijdschr Tandheelkd; 2008 Feb; 115(2):61-8. PubMed ID: 18326400
[TBL] [Abstract][Full Text] [Related]
13. Pleiotropic features of syndromic craniosynostoses correlate with differential expression of fibroblast growth factor receptors 1 and 2 during human craniofacial development.
Chan CT; Thorogood P
Pediatr Res; 1999 Jan; 45(1):46-53. PubMed ID: 9890607
[TBL] [Abstract][Full Text] [Related]
14. Early mandibular morphological differences in patients with FGFR2 and FGFR3-related syndromic craniosynostoses: A 3D comparative study.
Morice A; Cornette R; Giudice A; Collet C; Paternoster G; Arnaud É; Galliani E; Picard A; Legeai-Mallet L; Khonsari RH
Bone; 2020 Dec; 141():115600. PubMed ID: 32822871
[TBL] [Abstract][Full Text] [Related]
15. Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts.
Mansukhani A; Bellosta P; Sahni M; Basilico C
J Cell Biol; 2000 Jun; 149(6):1297-308. PubMed ID: 10851026
[TBL] [Abstract][Full Text] [Related]
16. Fgfr2 and osteopontin domains in the developing skull vault are mutually exclusive and can be altered by locally applied FGF2.
Iseki S; Wilkie AO; Heath JK; Ishimaru T; Eto K; Morriss-Kay GM
Development; 1997 Sep; 124(17):3375-84. PubMed ID: 9310332
[TBL] [Abstract][Full Text] [Related]
17. Genetic control of the cell proliferation-differentiation balance in the developing skull vault: roles of fibroblast growth factor receptor signalling pathways.
Morriss-Kay GM; Iseki S; Johnson D
Novartis Found Symp; 2001; 232():102-16; discussion 116-21. PubMed ID: 11277075
[TBL] [Abstract][Full Text] [Related]
18. Craniosynostosis: from a clinical description to an understanding of bone formation of the skull.
Lajeunie E; Catala M; Renier D
Childs Nerv Syst; 1999 Nov; 15(11-12):676-80. PubMed ID: 10603009
[TBL] [Abstract][Full Text] [Related]
19. ARQ 087 inhibits FGFR signaling and rescues aberrant cell proliferation and differentiation in experimental models of craniosynostoses and chondrodysplasias caused by activating mutations in FGFR1, FGFR2 and FGFR3.
Balek L; Gudernova I; Vesela I; Hampl M; Oralova V; Kunova Bosakova M; Varecha M; Nemec P; Hall T; Abbadessa G; Hatch N; Buchtova M; Krejci P
Bone; 2017 Dec; 105():57-66. PubMed ID: 28826843
[TBL] [Abstract][Full Text] [Related]
20. Dura in the pathogenesis of syndromic craniosynostosis: fibroblast growth factor receptor 2 mutations in dural cells promote osteogenic proliferation and differentiation of osteoblasts.
Ang BU; Spivak RM; Nah HD; Kirschner RE
J Craniofac Surg; 2010 Mar; 21(2):462-7. PubMed ID: 20489451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
